Cyfuse Biomedical K.K. (4892)
JPX JPX Primary Summary
4892 Chart
Cyfuse Biomedical K.K. (4892) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Cyfuse Biomedical K.K. ever had a stock split?
Cyfuse Biomedical K.K. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Shizuka Akieda CEO | JPX Exchange | JP3311800001 ISIN |
| Japan Country | 23 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Cyfuse Biomedical K.K. is a pioneering company based in Tokyo, Japan, founded in 2010. This innovative firm is dedicated to advancing the field of regenerative medicine through the development, manufacture, and sale of cutting-edge regenerative medicine products in Japan. It specializes in creating cellular products aimed at regenerative therapy and also provides contract services for the research and development of cellular products. Cyfuse Biomedical K.K. is at the forefront of leveraging biotechnological advancements to foster developments in tissue and organ regeneration, significantly contributing to the advancement of healthcare and medical treatments.
Products and Services
- Bio 3D Printer
This innovative product by Cyfuse Biomedical K.K. is designed for the regeneration of various tissues and organs, including cartilage, bones, blood vessels, and nerves. Utilizing cutting-edge technology, the Bio 3D Printer facilitates the creation of 3D biological structures by precisely stacking cells, thus offering promising solutions for tissue engineering and regenerative medicine.
- Regenova
Regenova is a sophisticated bio 3D printer developed by Cyfuse Biomedical for the 3D stacking of cells. It represents a significant step forward in regenerative medicine, providing researchers and clinicians with the ability to fabricate complex, three-dimensional tissues that mimic the natural tissue architecture. This technology is instrumental in the development of functional tissues for therapeutic and research applications.
- S-PIKE
S-PIKE is an advanced technology platform offered by Cyfuse Biomedical that specializes in developing 3D-structures from cells. It paves the way for the creation of precise and functional three-dimensional tissues and organs, which can be used in various medical applications, including transplantation, disease modeling, and drug screening. S-PIKE represents Cyfuse Biomedical’s commitment to innovation in 3D bioprinting and regenerative medicine.
